Aminopterin clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 1997
How each study uses Aminopterin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- aminopterin
- 4
Studies by the year they started
4 studies that test it; most in 1997 (1)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 1998 | 1 |
| 2001 | 1 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Genzyme, a Sanofi Company (2) · Syntrix Biosystems, Inc. (1) · Rutgers, The State University of New Jersey (1)
Often tested with
Tested in the same studies.
Cyclophosphamide (1) · Cytarabine (1) · Methotrexate (1) · Thioguanine (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antimetabolites source
Studies
Open first, then newest update. How each study uses Aminopterin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Aminopterin Pharmacokinetic Study In Moderate to Severe PsoriasisCompletedPhase 1Syntrix Biosystems, Inc.NCT00937027Written as AminopterinHow we know
- Aminopterin in Treating Patients With Recurrent or Refractory Endometrial CancerWithdrawnPhase 2Genzyme, a Sanofi CompanyNCT00003821Written as aminopterinHow we know
- CINJALL: Treatment for Children With Acute Lymphocytic LeukemiaCompletedPhase 2Rutgers, The State University of New JerseyNCT00176462Written as aminopterinHow we know
- Aminopterin in Treating Patients With Refractory LeukemiaCompletedPhase 2Genzyme, a Sanofi CompanyNCT00003305Written as aminopterinHow we know
Codes
What other systems call Aminopterin · ClinicalTrials.gg INT006954
- MeSH (NLM) D000630AminopterinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) JYB41CTM2QAMINOPTERINConfirmed FDA, NLM, Wikidata
- RxNorm 1440264Confirmed FDA, Wikidata
- Wikidata Q415734aminopterinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C235AminopterinOne source FDA
- DrugBank DB08878One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000630 | Aminopterin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | JYB41CTM2Q | AMINOPTERIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1440264 | — | Confirmed FDA, Wikidata |
| Wikidata | Q415734 | aminopterin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C235 | Aminopterin | One source FDA |
| DrugBank | DB08878 | — | One source Wikidata |
Also registered as aminopterin sodium (UNII FZU1QI13O9 · RxNorm 1440263).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.